High-level expression of stem cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis

Oncology Letters

Volumn 2, Issue 6, 2011, Pages 1095-1100

  Kim, Kyungeun ^a   Ihm, Hyojin ^b   Ro, Jae Y ^b   Cho, Yong Mee ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

CD133; Clear cell renal cell carcinoma; Ki 67; Metastasis; Oct 4

Indexed keywords

CD133 ANTIGEN; KI 67 ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLEAR CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; TUMOR DIFFERENTIATION;

EID: 80052718620     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.368     Document Type: Article

References (46)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 59: 225-249, 2009.
2. Wein AJ, Kavoussi LR, Novick AC, Partin AW and Peters CA: Campbell-Walsh Urology. 9th edition. Saunders Elsevier, Philadelphia, 2007.
3. Levy DA, Slaton JW, Swanson DA and Dinney CP: Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159: 1163-1167, 1998.
4. Eble JN, Epstein JI and Sesterhenn IA: World Health Organization classification of tumors. IARC Press, Lyon, 2004.
5. Kim HL, Seligson D, Liu X, et al: Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res 10: 5464-5471, 2004.
6. Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 414: 105-111, 2001.
7. Clarke MF, Dick JE, Dirks PB, et al: Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344, 2006.
8. Burkert J, Wright NA and Alison MR: Stem cells and cancer: an intimate relationship. J Pathol 209: 287-297, 2006.
9. Brabletz T, Jung A, Spaderna S, Hlubek F and Kirchner T: Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749, 2005.
10. Miraglia S, Godfrey W, Yin AH, et al: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90: 5013-5021, 1997.
11. Mizrak D, Brittan M and Alison MR: CD 133: molecule of the moment. J Pathol 214: 3-9, 2008.
12. Horst D, Kriegl L, Engel J, Kirchner T and Jung A: Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest 27: 844-850, 2009.
13. Wang Q, Chen ZG, Du CZ, Wang HW, Yan L and Gu J: Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer. Histopathology 55: 284-293, 2009.
14. Kojima M, Ishii G, Atsumi N, Fujii S, Saito N and Ochiai A: Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study. Cancer Sci 99: 1578-1583, 2008.
15. Bussolati B, Bruno S, Grange C, et al: Isolation of renal progenitor cells from adult human kidney. Am J Pathol 166: 545-555, 2005.
16. Florek M, Haase M, Marzesco AM, et al: Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 319: 15-26, 2005.
17. Cheville JC, Lohse CM, Zincke H, Weaver AL and Blute ML: Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27: 612-624, 2003.
18. Cheng L, Sung MT, Cossu-Rocca P, et al: OCT 4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 211: 1-9, 2007.
19. Jones TD, Ulbright TM, Eble JN and Cheng L: OCT 4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 10: 8544-8547, 2004.
20. Lengner CJ, Welstead GG and Jaenisch R: The pluripotency regulator Oct 4: a role in somatic stem cells? Cell Cycle 7: 725-728, 2008.
21. Fuhrman SA, Lasky LC and Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655-663, 1982.
22. Greene FL and Fleming ID: AJCC Cancer Staging Manual. 6thedition. Springer-Verlag, Chicago, 2002.
23. Kim K, Lee KM, Han DJ, Yu E and Cho YM: Adult stem cell-like tubular cells reside in the corticomedullary junction of the kidney. Int J Clin Exp Pathol 1: 232-241, 2008.
24. Gupta PB, Chaffer CL and Weinberg RA: Cancer stem cells: mirage or reality? Nat Med 15: 1010-1012, 2009.
25. Tirino V, Camerlingo R, Franco R, et al: The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur J Cardiothorac Surg 36: 446-453, 2009.
26. Rutella S, Bonanno G, Procoli A, et al: Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin Cancer Res 15: 4299-4311, 2009.
27. Yin AH, Miraglia S, Zanjani ED, et al: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012, 1997.
28. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110, 2007.
29. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al: Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115, 2007.
30. Zeppernick F, Ahmadi R, Campos B, et al: Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14: 123-129, 2008.
31. Artells R, Moreno I, Diaz T, et al: Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Eur J Cancer 46: 642-649, 2010.
32. Todaro M, Alea MP, Di Stefano AB, et al: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1: 389-402, 2007.
33. Bao S, Wu Q, McLendon RE, et al: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760, 2006.
34. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA and Rosen JM: WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 104: 618-623, 2007.
35. Chiou SH, Kao CL, Chen YW, et al: Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One 3: e2090, 2008.
36. Smith LM, Nesterova A, Ryan MC, et al: CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer 99: 100-109, 2008.
37. Ferrandina G, Martinelli E, Petrillo M, et al: CD133 antigen expression in ovarian cancer. BMC Cancer 9: 221, 2009.
38. Piras F, Perra MT, Murtas D, et al: The stem cell marker nestin predicts poor prognosis in human melanoma. Oncol Rep 23: 17-24, 2010.
39. + renal progenitor cells contribute to tumor angiogenesis. Am J Pathol 169: 2223-2235, 2006.
40. Corbeil D, Roper K, Hellwig A, et al: The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275: 5512-5520, 2000.
41. Fargeas CA, Joester A, Missol-Kolka E, Hellwig A, Huttner WB and Corbeil D: Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J Cell Sci 117: 4301-4311, 2004.
42. Giebel B, Corbeil D, Beckmann J, et al: Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. Blood 104: 2332-2338, 2004.
43. Weigmann A, Corbeil D, Hellwig A and Huttner WB: Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA 94: 12425-12430, 1997.
44. Corbeil D, Roper K, Fargeas CA, Joester A and Huttner WB: Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2: 82-91, 2001.
45. Rousseau A, Ayoubi F, Deveaux C, et al: Impact of age and gender interaction on circulating endothelial progenitor cells in healthy subjects. Fertil Steril 93: 843-846, 2010.
46. Lemieux C, Cloutier I and Tanguay JF: Menstrual cycle influences endothelial progenitor cell regulation: a link to gender differences in vascular protection? Int J Cardiol 136: 200-210, 2009.